IROBOT CORP (IRBT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IRBT • US4627261005

0.4664 USD
-0.2 (-30.05%)
At close: Dec 19, 2025
0.4999 USD
+0.03 (+7.18%)
After Hours: 12/19/2025, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, IRBT scores 1 out of 10 in our fundamental rating. IRBT was compared to 60 industry peers in the Household Durables industry. IRBT may be in some trouble as it scores bad on both profitability and health. IRBT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year IRBT has reported negative net income.
  • In the past year IRBT has reported a negative cash flow from operations.
  • In multiple years IRBT reported negative net income over the last 5 years.
  • In the past 5 years IRBT reported 4 times negative operating cash flow.
IRBT Yearly Net Income VS EBIT VS OCF VS FCFIRBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -43.34%, IRBT is doing worse than 95.08% of the companies in the same industry.
Industry RankSector Rank
ROA -43.34%
ROE N/A
ROIC N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
IRBT Yearly ROA, ROE, ROICIRBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • With a Gross Margin value of 23.24%, IRBT is not doing good in the industry: 62.30% of the companies in the same industry are doing better.
  • IRBT's Gross Margin has declined in the last couple of years.
  • IRBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
IRBT Yearly Profit, Operating, Gross MarginsIRBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IRBT has been increased compared to 1 year ago.
  • IRBT has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, IRBT has a worse debt to assets ratio.
IRBT Yearly Shares OutstandingIRBT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IRBT Yearly Total Debt VS Total AssetsIRBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • IRBT has an Altman-Z score of -1.51. This is a bad value and indicates that IRBT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -1.51, IRBT is not doing good in the industry: 93.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.51
ROIC/WACCN/A
WACC9.27%
IRBT Yearly LT Debt VS Equity VS FCFIRBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • IRBT has a Current Ratio of 0.52. This is a bad value and indicates that IRBT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.52, IRBT is doing worse than 96.72% of the companies in the same industry.
  • A Quick Ratio of 0.22 indicates that IRBT may have some problems paying its short term obligations.
  • The Quick ratio of IRBT (0.22) is worse than 96.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.22
IRBT Yearly Current Assets VS Current LiabilitesIRBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • IRBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.58%, which is quite good.
  • IRBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.08%.
  • The Revenue for IRBT have been decreasing by -10.90% on average. This is quite bad
EPS 1Y (TTM)14.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-866.67%
Revenue 1Y (TTM)-33.08%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-24.63%

3.2 Future

  • The Earnings Per Share is expected to grow by 33.99% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 9.89% on average over the next years. This is quite good.
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IRBT Yearly Revenue VS EstimatesIRBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
IRBT Yearly EPS VS EstimatesIRBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IRBT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IRBT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRBT Price Earnings VS Forward Price EarningsIRBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRBT Per share dataIRBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IRBT's earnings are expected to grow with 33.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.99%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • IRBT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IROBOT CORP

NASDAQ:IRBT (12/19/2025, 8:00:02 PM)

After market: 0.4999 +0.03 (+7.18%)

0.4664

-0.2 (-30.05%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-06
Earnings (Next)05-04
Inst Owners39.47%
Inst Owner Change-19.76%
Ins Owners3.27%
Ins Owner Change-2.1%
Market Cap14.85M
Revenue(TTM)547.00M
Net Income(TTM)-208.72M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.84%
Min EPS beat(2)65.31%
Max EPS beat(2)76.37%
EPS beat(4)2
Avg EPS beat(4)18.52%
Min EPS beat(4)-50.53%
Max EPS beat(4)76.37%
EPS beat(8)5
Avg EPS beat(8)32.32%
EPS beat(12)6
Avg EPS beat(12)-56.92%
EPS beat(16)8
Avg EPS beat(16)-48.15%
Revenue beat(2)2
Avg Revenue beat(2)2.57%
Min Revenue beat(2)0.05%
Max Revenue beat(2)5.1%
Revenue beat(4)2
Avg Revenue beat(4)-5.48%
Min Revenue beat(4)-20.34%
Max Revenue beat(4)5.1%
Revenue beat(8)3
Avg Revenue beat(8)-4.9%
Revenue beat(12)4
Avg Revenue beat(12)-8.65%
Revenue beat(16)4
Avg Revenue beat(16)-10.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.51
EYN/A
EPS(NY)-1.13
Fwd EYN/A
FCF(TTM)-3.36
FCFYN/A
OCF(TTM)-3.36
OCFYN/A
SpS17.18
BVpS-0.84
TBVpS-6.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.24%
FCFM N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.22
Altman-Z -1.51
F-Score4
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)11.65%
Cap/Depr(5y)43.11%
Cap/Sales(3y)0.46%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-866.67%
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.08%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-24.63%
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-104.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4377.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1288.32%
OCF growth 3YN/A
OCF growth 5YN/A

IROBOT CORP / IRBT FAQ

What is the fundamental rating for IRBT stock?

ChartMill assigns a fundamental rating of 1 / 10 to IRBT.


What is the valuation status of IROBOT CORP (IRBT) stock?

ChartMill assigns a valuation rating of 1 / 10 to IROBOT CORP (IRBT). This can be considered as Overvalued.


What is the profitability of IRBT stock?

IROBOT CORP (IRBT) has a profitability rating of 0 / 10.


How financially healthy is IROBOT CORP?

The financial health rating of IROBOT CORP (IRBT) is 0 / 10.